1 |
Baclofen
| [1] Baclofen Baclofen | [2] BACLOFEN BACLOFEN; Kemstro; | [2] GABBR1 GABBR1, GABBR2 💬 | [7] Estrogen signaling pathway Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬 | [7] 2 2, 10, 13, 18, 65, 149, 206 |
2 |
Botulinum toxin type A
| [1] Botulinum toxin type A Botulinum toxin type A | [8] Botox Botox; Botulinum toxin A; Botulinum toxin type A; BTX-A; Dysport; IncobotulinumtoxinA; OnabotulinumtoxinA; Xeomin; | [1] SNAP25 SNAP25 💬 | [2] Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | [13] 2 2, 5, 6, 7, 13, 15, 17, 36, 51, 70, 113, 149, 226 |
3 |
Flunarizine hydrochloride
| [1] Flunarizine Flunarizine | [0] | [3] CACNA1G CACNA1G, CACNA1H, CACNA1I 💬 | [8] Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GnRH secretion, MAPK signaling pathway, Type II diabetes mellitus 💬 | [4] 58 58, 86, 149, 215 |
4 |
Sodium oxybate
| [1] Sodium oxybate Sodium oxybate | [1] Sodium Oxybate Sodium Oxybate; | - | - | [2] 6 6, 149 |
5 |
Lacosamide
| [1] Lacosamide Lacosamide | [1] Lacosamide Lacosamide; | [2] SCN3A SCN3A, SCN9A 💬 | [1] Taste transduction Taste transduction 💬 | [3] 2 2, 46, 149 |
6 |
Fenfluramine
| [1] Fenfluramine Fenfluramine | [2] Fenfluramina Fenfluramina; FENFLURAMINE; | [4] HTR2A HTR2A, HTR2B, HTR2C, SLC6A4 💬 | [6] Calcium signaling pathway Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬 | [4] 140 140, 144, 145, 149 |
7 |
Flunarizine
| [1] Flunarizine Flunarizine | [0] | [3] CACNA1G CACNA1G, CACNA1H, CACNA1I 💬 | [8] Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GnRH secretion, MAPK signaling pathway, Type II diabetes mellitus 💬 | [4] 58 58, 86, 149, 215 |
8 |
Melatonin
| [1] Melatonin Melatonin | [2] Circadin Circadin; Melatonin; | [2] MTNR1A MTNR1A, MTNR1B 💬 | [2] Circadian entrainment Circadian entrainment, Neuroactive ligand-receptor interaction 💬 | [12] 6 6, 8, 13, 37, 46, 49, 90, 97, 144, 145, 149, 202 |
9 |
Brivaracetam
| [1] Brivaracetam Brivaracetam | [1] BRIVARACETAM BRIVARACETAM; | [1] SV2A SV2A 💬 | [1] ECM-receptor interaction ECM-receptor interaction 💬 | [2] 149 149, 309 |
10 |
Carbon monoxide
| [1] Carbon monoxide Carbon monoxide | [1] Carbon monoxide Carbon monoxide; | - | - | [8] 6 6, 13, 53, 70, 85, 86, 149, 298 |
11 |
Triheptanoin
| [1] Triheptanoin Triheptanoin | [1] Triheptanoin Triheptanoin; | - | - | [10] 2 2, 8, 65, 149, 156, 248, 256, 257, 317, 324 |
12 |
Padsevonil
| [1] Padsevonil Padsevonil | [1] Padsevonil Padsevonil; | [3] SV2A SV2A, SV2B, SV2C 💬 | [1] ECM-receptor interaction ECM-receptor interaction 💬 | [1] 149 149 |